- Home
- CLCO vs CYRX Comparison
CLCO vs CYRX Comparison
Compare CLCO & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLCO
- CYRX
- Stock Information
- Founded
- CLCO 2018
- CYRX 1999
- Country
- CLCO United Kingdom
- CYRX United States
- Employees
- CLCO N/A
- CYRX N/A
- Industry
- CLCO
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- CLCO
- CYRX Health Care
- Exchange
- CLCO Nasdaq
- CYRX Nasdaq
- Market Cap
- CLCO 360.2M
- CYRX 365.5M
- IPO Year
- CLCO N/A
- CYRX N/A
- Fundamental
- Price
- CLCO $6.66
- CYRX $7.85
- Analyst Decision
- CLCO
- CYRX Strong Buy
- Analyst Count
- CLCO 0
- CYRX 10
- Target Price
- CLCO N/A
- CYRX $10.90
- AVG Volume (30 Days)
- CLCO 45.1K
- CYRX 488.7K
- Earning Date
- CLCO 08-28-2025
- CYRX 08-05-2025
- Dividend Yield
- CLCO 8.98%
- CYRX N/A
- EPS Growth
- CLCO N/A
- CYRX N/A
- EPS
- CLCO 1.31
- CYRX N/A
- Revenue
- CLCO $320,759,000.00
- CYRX $232,134,000.00
- Revenue This Year
- CLCO $2.03
- CYRX N/A
- Revenue Next Year
- CLCO N/A
- CYRX $9.59
- P/E Ratio
- CLCO $5.05
- CYRX N/A
- Revenue Growth
- CLCO N/A
- CYRX 11.75
- 52 Week Low
- CLCO $4.51
- CYRX $4.58
- 52 Week High
- CLCO $12.45
- CYRX $9.66
- Technical
- Relative Strength Index (RSI)
- CLCO 45.41
- CYRX 59.21
- Support Level
- CLCO $6.66
- CYRX $6.70
- Resistance Level
- CLCO $6.97
- CYRX $8.45
- Average True Range (ATR)
- CLCO 0.21
- CYRX 0.41
- MACD
- CLCO -0.03
- CYRX 0.02
- Stochastic Oscillator
- CLCO 12.50
- CYRX 65.71
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.